Big pharma - Bayer's heavyweight buy

被引：0
|
作者：
Eisberg, N
机构：
来源：
CHEMISTRY & INDUSTRY | 2006年 / 07期
关键词：
D O I：
暂无
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Pharma spends big to buy influence
    不详
    NATURE MEDICINE, 2010, 16 (03) : 243 - 243
  • [2] Pharma spends big to buy influence
    Nature Medicine, 2010, 16 : 243 - 243
  • [3] Bayer, Novartis, Pfizer Raise Big Pharma's Stake in Gene Therapy
    Philippidis, Alex
    HUMAN GENE THERAPY, 2020, 31 (23-24) : 1221 - 1223
  • [4] Bayer lapse exposes pharma's vulnerability
    John Hodgson
    Nature Biotechnology, 2001, 19 : 897 - 898
  • [5] Bayer lapse exposes pharma's vulnerability
    Hodgson, J
    NATURE BIOTECHNOLOGY, 2001, 19 (10) : 897 - 898
  • [6] Bayer Schering Pharma
    不详
    CHEMIE IN UNSERER ZEIT, 2006, 40 (04) : 280 - 280
  • [7] Big pharma's commedia
    Steele, FR
    CELL, 2005, 123 (06) : 971 - 973
  • [8] Big pharma's payoff
    不详
    NATION, 2001, 273 (15) : 3 - 3
  • [9] Big Pharma's Friend
    Konrad, Alex
    FORBES, 2017, 199 (06): : 46 - +
  • [10] Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case
    Kogej, Thierry
    Blomberg, Niklas
    Greasley, Peter J.
    Mundt, Stefan
    Vainio, Mikko J.
    Schamberger, Jens
    Schmidt, Georg
    Huelser, Joerg
    DRUG DISCOVERY TODAY, 2013, 18 (19-20) : 1014 - 1024
12345